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ttiología viral en neoplasias hematoló
n recent years, a group of infectious agents, mostly viral in
ature, have been associated with the development of
alignant diseases. The ﬁrst human oncogenic virus, the
pstein-Barr virus (EBV), was described 51 years ago, which
as isolated from pediatric patients with Burkitt’s lym-
homa who resided in Equatorial Africa. This discovery
stablished the basis for viral oncology, which today recog-
izes eight viral agents directly or indirectly associated with
uman cancer.
EBV is a member of the herpesviruses family and
ogether with Kaposi’s sarcoma-associated herpesvirus are
he prototypical representatives of the subfamily of the
ammaherpesviruses. These viruses are characterized by
heir ability to signiﬁcantly induce lymphomas and sarco-
as in immunocompromised individuals. Similarly, members
f the subfamily of the betaherpesviruses, such as the
ytomegalovirus (CMV), human herpesvirus type 6 and
uman herpesvirus type 7, are being recognized as important
gents associated with human neoplasms that favor tumor
ggressiveness. CMV together with EBV are viral agents of
reat signiﬁcance for immunocompromised individuals, par-
icularly those who are treated with immunosuppressive
rugs to prevent rejection after solid organ transplanta-
ion. All these viruses are characterized for encoding their
wn battery of genes, which imitate cellular processes
nd allow chronic infections to be established, lasting the
ntire lifetime of the host. The same genes that perpetu-
te life of the infected cell and interfere in its process of
eplication are the oncogenes responsible for its malignant
ransformation. Understanding these persistent viral mech-
nisms will provide a signiﬁcant control of the associated
iseases.
Currently, EBV is recognized as the oncogenic agent
ost strongly related with pediatric cancers. In children,
his agent is associated with a set of diseases ranging
rom infectious mononucleosis to lymphomas, particularly
n immunosuppressed individuals. This special issue of the
oletin Médico del Hospital Infantil de México (BMHIM) has
he objective of highlighting the growing importance of
iral agents in the development of neoplasms in the pedia-
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ric population, mainly EBV, but also of other members of
he herpesviruses family. These neoplasms include post-
ransplant lymphoproliferative disease and different types
f lymphomas, including Burkitt’s lymphoma, Hodgkin’s lym-
homa and diffuse large B-cell lymphoma. More recently,
BV is also recognized as the causal agent of a fraction of the
-cell lymphomas and NK cell lymphomas and a new entity
alled hemophagocytic lymphohistiocytosis. This issue of
MHIM gathers original articles, review articles and clini-
al case reports of researchers located in different research
enters and hospitals worldwide who share their experiences
n the study, diagnosis and treatment of this set of diseases.
Chabay and Preciado present the epidemiological
anorama of pediatric lymphomas associated with EBV in
rgentina.1 This work represents one of the few reports of
ediatric lymphomas and EBV done in developing countries
nd out of Africa. It shows that in a Latin American country
he epidemiological behavior of these neoplasms is different
rom that of developed countries, with a higher incidence
f EBV-positive cases and with an earlier presentation.
Presenting part of the experience of the medical cen-
ers to which they are afﬁliated, Martín-Mateos and Piquer
rom Spain2 and Lee and Ko from South Korea3 present case
eports of common variable immunodeﬁciency and chronic
ctive EBV infections, respectively: two diseases that have
een relatively recently recognized as important risk fac-
ors in the development of lymphomas. Jiménez-Hernández
t al. from Mexico present a case of hemophagocytic lym-
hohistiocytosis probably associated with EBV.4 This case
ighlights that these types of diseases also occur in Mex-
co, up to now mainly studied in Asian countries or in the
.S. Reyes-Pérez et al., in an original article, approach
he importance of continuous CMV monitoring in pediatric
atients who are pharmacologically immunosuppressed due
o a solid organ transplantation. This article also conﬁrms
he importance of monitoring drug levels in the blood and
5o not be based solely on the dosage given.
In an interesting review article, R. Rochford, of
he University of Denver, discusses epidemiological and
xperimental evidence on the probable mechanisms of
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transformation  that  occur  in  endemic  Burkitt’s  lymphoma
of Equatorial  Africa.6 In  this  speciﬁc  type  of  lymphoma,  co-
infection with  the  Plasmodium  falciparum  parasite,  which
causes malaria,  is  a  critical  factor.  Taking  into  consider-
ation the  article  by  Chabay  and  Preciado,  who  arrive  at  the
conclusion that  the  incidence  of  lymphomas  associated  with
EBV is  very  high  in  Argentina  and  its  presentation  is  ear-
lier than  in  developed  countries,1 it  would  be  important  to
identify which  infections  act  as  co-factors  in  the  develop-
ment of  Burkitt’s  lymphoma  in  countries  in  which  malaria  is
not prevalent,  but  where  the  incidence  of  this  EBV-positive
lymphoma is  high  in  pediatric  populations.
The  Rouce  working  group  from  Baylor  College
of Medicine,  Houston,  a  world  leader  in  the  area  of
immunotherapy against  cancer,  presents  an  opinion  based
on their  personal  experience  on  risk  factors,  diagnosis  and
management of  posttransplant  lymphoproliferative  diseases
and EBV.7 Finally,  J.M.  Mejía-Aranguré  discusses  a  model
of causality  of  pediatric  acute  leukemias  that  includes
infections as  possible  risk  factors  in  their  development.8
In  summary,  lymphomas  are  the  third  most  common  type
of cancer  in  the  pediatric  population  and  leukemia  is  the
most common.  This  special  edition  emphasizes  the  impor-
tance of  viral  infections,  especially  by  members  of  the
herpesviruses family,  in  the  development  of  lymphomas,
with the  objective  of  intensifying  its  study,  especially  in
developing countries  such  as  Mexico,  with  very  poor  under-
standing in  this  regard.  The  study  of  viruses  associated  with
malignant processes  has  resulted  in  the  Nobel  Prize  for  Dr.
Harald zur  Hausen  for  the  discovery  of  the  human  papil-
loma virus  and  for  Dr.  Luc  Montagnier  for  the  discovery  of
the human  immunodeﬁciency  virus.  This  knowledge  has  also
resulted in  the  generation  of  two  vaccines  that  will  help  in
the control  of  cervical  cancer  and  liver  cancer.  In  the  future,
it is  advisable  to  have  better  tools  for  the  control  of  pedi-
atric malignancies,  which  are  importantly  associated  with
viral infections. e3
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